Cargando…

The Left Atrial Septal Pouch: A New Stroke Risk Factor?

The left atrial septal pouch (LASP) occurs due to incomplete fusion of septa primum and secundum at the inter-atrial septum, creating an open flap that may serve as a thromboembolic source. Prior studies have demonstrated increased prevalence of LASP in cryptogenic strokes. The aim of the current st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Ruchi, Wadi, Lara, Becerra, Brian, Eskander, Michael, Razmara, Ali, Lombardo, Dawn, Paganini-Hill, Annlia, Kim, Jin Kyung, Fisher, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925453/
https://www.ncbi.nlm.nih.gov/pubmed/33393056
http://dx.doi.org/10.1007/s12975-020-00864-3
_version_ 1783659270823215104
author Kapoor, Ruchi
Wadi, Lara
Becerra, Brian
Eskander, Michael
Razmara, Ali
Lombardo, Dawn
Paganini-Hill, Annlia
Kim, Jin Kyung
Fisher, Mark
author_facet Kapoor, Ruchi
Wadi, Lara
Becerra, Brian
Eskander, Michael
Razmara, Ali
Lombardo, Dawn
Paganini-Hill, Annlia
Kim, Jin Kyung
Fisher, Mark
author_sort Kapoor, Ruchi
collection PubMed
description The left atrial septal pouch (LASP) occurs due to incomplete fusion of septa primum and secundum at the inter-atrial septum, creating an open flap that may serve as a thromboembolic source. Prior studies have demonstrated increased prevalence of LASP in cryptogenic strokes. The aim of the current study was to validate the above findings in a separate, larger group of stroke and non-stroke patients. We examined transesophageal echocardiograms (TEEs) performed between July 2011 and December 2018. LASP prevalence was determined in TEEs referred for ischemic stroke or transient ischemic attack (“stroke”) and compared with LASP prevalence in patients undergoing TEEs for other reasons (“non-stroke”). Stroke subtyping was performed using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. There were 306 TEEs from 144 non-stroke and 162 stroke patients. Mean age and sex distribution were 56 ± 1 (mean ± SE) and 65% male in the non-stroke group and 58 ± 1 and 54% male in the stroke group. The overall prevalence of LASP was 31%. The prevalence of LASP was 28% (41/144) in non-stroke patients, 25% (24/95) in non-cryptogenic stroke patients, and 43% (29/67) in cryptogenic stroke patients. LASP prevalence was significantly higher in the cryptogenic subgroup compared with the non-cryptogenic subgroup (p = 0.02). These findings demonstrate a significant association of LASP with risk of cryptogenic stroke, suggesting that LASP may serve as a thromboembolic nidus. Additional studies are needed to determine the generalizability of these findings, and their therapeutic implications, supporting LASP as a stroke risk factor.
format Online
Article
Text
id pubmed-7925453
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-79254532021-03-19 The Left Atrial Septal Pouch: A New Stroke Risk Factor? Kapoor, Ruchi Wadi, Lara Becerra, Brian Eskander, Michael Razmara, Ali Lombardo, Dawn Paganini-Hill, Annlia Kim, Jin Kyung Fisher, Mark Transl Stroke Res Original Article The left atrial septal pouch (LASP) occurs due to incomplete fusion of septa primum and secundum at the inter-atrial septum, creating an open flap that may serve as a thromboembolic source. Prior studies have demonstrated increased prevalence of LASP in cryptogenic strokes. The aim of the current study was to validate the above findings in a separate, larger group of stroke and non-stroke patients. We examined transesophageal echocardiograms (TEEs) performed between July 2011 and December 2018. LASP prevalence was determined in TEEs referred for ischemic stroke or transient ischemic attack (“stroke”) and compared with LASP prevalence in patients undergoing TEEs for other reasons (“non-stroke”). Stroke subtyping was performed using the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. There were 306 TEEs from 144 non-stroke and 162 stroke patients. Mean age and sex distribution were 56 ± 1 (mean ± SE) and 65% male in the non-stroke group and 58 ± 1 and 54% male in the stroke group. The overall prevalence of LASP was 31%. The prevalence of LASP was 28% (41/144) in non-stroke patients, 25% (24/95) in non-cryptogenic stroke patients, and 43% (29/67) in cryptogenic stroke patients. LASP prevalence was significantly higher in the cryptogenic subgroup compared with the non-cryptogenic subgroup (p = 0.02). These findings demonstrate a significant association of LASP with risk of cryptogenic stroke, suggesting that LASP may serve as a thromboembolic nidus. Additional studies are needed to determine the generalizability of these findings, and their therapeutic implications, supporting LASP as a stroke risk factor. Springer US 2021-01-04 2021 /pmc/articles/PMC7925453/ /pubmed/33393056 http://dx.doi.org/10.1007/s12975-020-00864-3 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Kapoor, Ruchi
Wadi, Lara
Becerra, Brian
Eskander, Michael
Razmara, Ali
Lombardo, Dawn
Paganini-Hill, Annlia
Kim, Jin Kyung
Fisher, Mark
The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title_full The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title_fullStr The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title_full_unstemmed The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title_short The Left Atrial Septal Pouch: A New Stroke Risk Factor?
title_sort left atrial septal pouch: a new stroke risk factor?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925453/
https://www.ncbi.nlm.nih.gov/pubmed/33393056
http://dx.doi.org/10.1007/s12975-020-00864-3
work_keys_str_mv AT kapoorruchi theleftatrialseptalpouchanewstrokeriskfactor
AT wadilara theleftatrialseptalpouchanewstrokeriskfactor
AT becerrabrian theleftatrialseptalpouchanewstrokeriskfactor
AT eskandermichael theleftatrialseptalpouchanewstrokeriskfactor
AT razmaraali theleftatrialseptalpouchanewstrokeriskfactor
AT lombardodawn theleftatrialseptalpouchanewstrokeriskfactor
AT paganinihillannlia theleftatrialseptalpouchanewstrokeriskfactor
AT kimjinkyung theleftatrialseptalpouchanewstrokeriskfactor
AT fishermark theleftatrialseptalpouchanewstrokeriskfactor
AT kapoorruchi leftatrialseptalpouchanewstrokeriskfactor
AT wadilara leftatrialseptalpouchanewstrokeriskfactor
AT becerrabrian leftatrialseptalpouchanewstrokeriskfactor
AT eskandermichael leftatrialseptalpouchanewstrokeriskfactor
AT razmaraali leftatrialseptalpouchanewstrokeriskfactor
AT lombardodawn leftatrialseptalpouchanewstrokeriskfactor
AT paganinihillannlia leftatrialseptalpouchanewstrokeriskfactor
AT kimjinkyung leftatrialseptalpouchanewstrokeriskfactor
AT fishermark leftatrialseptalpouchanewstrokeriskfactor